These guidelines update previous guidance published in 2005. They have been revised by
a group who are members of the UK and Ireland Neuroendocrine Tumour Society with …

Carcinoid heart disease is a frequent occurrence in patients with carcinoid syndrome and is
responsible for substantial morbidity and mortality. The pathophysiology of carcinoid heart …

BACKGROUND The carcinoid syndrome is a rare cause of acquired valvular heart disease.
Although the typical echocardiographic features of carcinoid heart disease are well …

Carcinoid tumors were first described over 100 years ago by Lubarsch, who found multiple
tumors in the distal ileum of two patients at autopsy. 1 The term karzinoide was used by …

Restrictive cardiomyopathy is defined as heart-muscle disease that results in impaired
ventricular filling, with normal or decreased diastolic volume of either or both ventricles …

Background Little is known about factors related to prognosis in patients with carcinoid
disease. In this study we have tried to identify such factors. Patients and methods We have …

The Topol Solution gives you a complete print and multimedia package consisting of
Textbook of Cardiovascular Medicine, Third Edition, a DVD, and access to a wealth of online …

Carcinoid heart disease (CHD) is a rare cardiac manifestation occurring in patients with
advanced neuroendocrine tumours and the carcinoid syndrome, usually involving the right …

The human cardiovascular system is exposed to plasma 5-hydroxytryptamine (5-HT,
serotonin), usually released from platelets. 5-HT can produce harmful acute and chronic …

Background Although serotonin has been postulated as an etiologic agent in the
development of carcinoid heart disease, no direct evidence for different ambient serotonin …